trial

SCIT Versus TAR for Outpatients With Schizophrenia

NCTId NCT03446703
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 100 (actual)
Sponsored by University of Alcala
Primary completion 2016-10-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
100 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2013-09-01
Primary completion
2016-10-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
SCITTAR

Sponsors

University of AlcalaLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2016-10-01
Status
COMPLETED
relationships
The graph out of here
drug
SCIT
drug
TAR
drug
lead_sponsor
University of Alcala
company
indication
Schizophrenia
indication
Schizophrenia
indication